RNAi sector buzz lifts ALNY
Alnylam is rallying moderately alongside a risk-on biotech tape, with news that a startup co-founded by its founder filed for IPO drawing fresh attention to the RNAi field the company pioneered.
Sources: https://www.bizjournals.com/boston/news/2026/09/25/john-maraganore-s-new-rnai-startup-plots-ipo.html
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works